1,867
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Efficacy and safety of ultrasonography-guided radiofrequency ablation for the treatment of T1bN0M0 papillary thyroid carcinoma: a retrospective study

ORCID Icon, , , ORCID Icon, , , , , & show all
Pages 392-398 | Received 07 Feb 2020, Accepted 01 Apr 2020, Published online: 28 Apr 2020

References

  • Kim J, Gosnell JE, Roman SA. Geographic influences in the global rise of thyroid cancer. Nat Rev Endocrinol. 2020;16(1):17–29.
  • Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12(11):646–653.
  • Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
  • Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140(4):317–322.
  • Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer. Clin Endocrinol. 2014;81 (Suppl 1):1–122.
  • Gharib H, Papini E, Garber JR, et al. American association of clinical endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidlines for clinical practice for the diagnosis and management of thyroid nodules-2016 update. Endocr Pract. 2016;22(Supplement 1):1–639.
  • Tuttle RM, Haugen B, Perrier ND. Updated American Joint Committee on cancer/tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer (eighth edition): what changed and why? Thyroid. 2017;27(6):751–756.
  • Anderson KL, Youngwirth LM, Scheri RP, et al. T1a versus T1b differentiated thyroid cancers: do we need to make the distinction? Thyroid. 2016;26(8):1046–1052.
  • Ito Y, Masuoka H, Fukushima M, et al. Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy. World J Surg. 2010;34(6):1285–1290.
  • Linos D, Economopoulos KP, Kiriakopoulos A, et al. Scar perceptions after thyroid and parathyroid surgery: comparison of minimal and conventional approaches. Surgery. 2013;153(3):400–407.
  • Wang TS, Sosa JA. Thyroid surgery for differentiated thyroid cancer – recent advances and future directions. Nat Rev Endocrinol. 2018;14(11):670–683.
  • Mauri G, Sconfienza LM. Image-guided thermal ablation might be a way to compensate for image deriving cancer overdiagnosis. Int J Hyperther. 2017;33(4):489–490.
  • Kim J, Baek JH, Lim HK, et al. 2017 thyroid radiofrequency ablation guideline: Korean Society of Thyroid Radiology. Korean J Radiol. 2018;19(4):632.
  • Dietrich CF, Müller T, Bojunga J, et al. Statement and recommendations on interventional ultrasound as a thyroid diagnostic and treatment procedure. Ultrasound Med Biol. 2018;44(1):14–36.
  • Papini E, Pacella CM, Solbiati LA, et al. Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group. Int J Hyperther. 2019;36(1):375–381.
  • Zhang M, Luo Y, Zhang Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid. 2016;26(11):1581–1587.
  • Ding M, Tang X, Cui D, et al. Clinical outcomes of ultrasound-guided radiofrequency ablation for the treatment of primary papillary thyroid microcarcinoma. Clin Radiol. 2019;74(9):712–717.
  • Zhang Y, Zhang MB, Luo YK, et al. Effect of chronic lymphocytic thyroiditis on the efficacy and safety of ultrasound‐guided radiofrequency ablation for papillary thyroid microcarcinoma. Cancer Med. 2019;8(12):5450–5458.
  • Lloyd RV, Osamura RY, Klöppel G, et al. WHO classification of tumors: pathology and genetics of tumors of endocrine organs. Lyon: IARC Press; 2017.
  • Guo Z, Ge M, Chu Y, et al. Recent advances in the classification of low-grade papillary-like thyroid neoplasms and aggressive papillary thyroid carcinomas: evolution of diagnostic criteria. Adv Anat Pathol. 2018;25(4):263–272.
  • Mauri G, Pacella CM, Papini E, et al. Image-guided thyroid ablation: proposal for standardization of terminology and reporting criteria. Thyroid. 2019;29(5):611–618.
  • Tessler FN, Middleton WD, Grant EG, et al. ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS Committee. J Am Coll Radiol. 2017;14(5):587–595.
  • Zhang Y, Zhou P, Tian S, et al. Usefulness of combined use of contrast-enhanced ultrasound and TI-RADS classification for the differentiation of benign from malignant lesions of thyroid nodules. Eur Radiol. 2017;27(4):1527–1536.
  • Park HS, Baek JH, Park AW, et al. Thyroid radiofrequency ablation: updates on innovative devices and techniques. Korean J Radiol. 2017;18(4):615–623.
  • Shin JH, Baek JH, Ha EJ, et al. Radiofrequency ablation of thyroid nodules: basic principles and clinical application. Int J Endocrinol. 2012;2012:1–7.
  • Zhang M, Tufano RP, Russell J, et al. Ultrasound-guided radiofrequency ablation versus surgery for low risk papillary thyroid micro-carcinoma: results of over 5 years follow-up. Thyroid. 2020;30(3):408–417.
  • Leenhardt L, Erdogan MF, Hegedus L, et al. 2013 European Thyroid Association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. Eur Thyroid J. 2013;2(3):147–159.
  • Mauri G, Cova L, Ierace T, et al. Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation. Cardiovasc Intervent Radiol. 2016;39(7):1023–1030.
  • Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology. 2014;273(1):241–260.
  • Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg. 2010;34(1):28–35.
  • Yuan Z, Wang Y, Zhang J, et al. A meta-analysis of clinical outcomes after radiofrequency ablation and microwave ablation for lung cancer and pulmonary metastases. J Am Coll Radiol. 2019;16(3):302–314.
  • Lee DH, Lee JM. Recent advances in the image-guided tumor ablation of liver malignancies: radiofrequency ablation with multiple electrodes, real-time multimodality fusion imaging, and new energy sources. Korean J Radiol. 2018;19(4):545–559.
  • Sanchez A, Feldman AS, Hakimi AA. Current management of small renal masses, including patient selection, renal tumor biopsy, active surveillance, and thermal ablation. J Clin Oncol. 2018;36(36):3591–3600.
  • Jeong WK, Baek JH, Rhim H, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol. 2008;18(6):1244–1250.
  • Mauri G, Gennaro N, Lee MK, et al. Laser and radiofrequency ablations for benign and malignant thyroid tumors. Int J Hyperther. 2019;36(2):13–20.
  • Kim JH, Yoo WS, Park YJ, et al. Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm. Radiology. 2015;276(3):909–918.
  • Lim HK, Baek JH, Lee JH, Kim WB, et al. Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer. Eur Radiol. 2015;25(1):163–170.
  • Wang LY, Nixon IJ, Palmer FL, et al. Comparable outcomes for patients with pT1a and pT1b differentiated thyroid cancer: is there a need for change in the AJCC classification system? Surgery. 2014;156(6):1484–1490.
  • Sakai T, Sugitani I, Ebina A, et al. Active surveillance for T1bN0M0 papillary thyroid carcinoma. Thyroid. 2019;29(1):59–63.
  • Kim J, Baek JH, Sung JY, Min HS, et al. Radiofrequency ablation of low-risk small papillary thyroid carcinoma: preliminary results for patients ineligible for surgery. Int J Hyperther. 2017;33(2):212–219.